• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态对比增强乳腺MRI中乳腺癌危险因素与乳腺实质背景强化之间的关联。

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI.

作者信息

Hellgren Roxanna, Saracco Ariel, Strand Fredrik, Eriksson Mikael, Sundbom Ann, Hall Per, Dickman Paul W

机构信息

Department of Medical Imaging, Division of Breast Imaging, Södersjukhuset, Stockholm, Sweden.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

出版信息

Acta Radiol. 2020 Dec;61(12):1600-1607. doi: 10.1177/0284185120911583. Epub 2020 Mar 26.

DOI:10.1177/0284185120911583
PMID:32216451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7720360/
Abstract

BACKGROUND

Background parenchymal enhancement (BPE) of normal tissue at breast magnetic resonance imaging is suggested to be an independent risk factor for breast cancer. Its association with established risk factors for breast cancer is not fully investigated.

PURPOSE

To study the association between BPE and risk factors for breast cancer in a healthy, non-high-risk screening population.

MATERIAL AND METHODS

We measured BPE and mammographic density and used data from self-reported questionnaires in 214 healthy women aged 43-74 years. We estimated odds ratios for the univariable association between BPE and risk factors. We then fitted an adjusted model using logistic regression to evaluate associations between BPE (high vs. low) and risk factors, including mammographic breast density.

RESULTS

The majority of women had low BPE (84%). In a multivariable model, we found statistically significant associations between BPE and age ( = 0.002) and BMI ( = 0.03). We did find a significant association between systemic progesterone medication and BPE, but due to small numbers, the results should be interpreted with caution. The adjusted odds ratio for high BPE was 3.1 among women with density D (compared to B) and 2.1 for density C (compared to B). However, the association between high BPE and density was not statistically significant. We did not find statistically significant associations with any other risk factors.

CONCLUSION

Our study confirmed the known association of BPE with age and BMI. Although our results show a higher likelihood for high BPE with increasing levels of mammographic density, the association was not statistically significant.

摘要

背景

乳腺磁共振成像中正常组织的背景实质强化(BPE)被认为是乳腺癌的一个独立危险因素。其与已确定的乳腺癌危险因素之间的关联尚未得到充分研究。

目的

研究健康、非高危筛查人群中BPE与乳腺癌危险因素之间的关联。

材料与方法

我们测量了214名年龄在43 - 74岁的健康女性的BPE和乳腺钼靶密度,并使用了自我报告问卷中的数据。我们估计了BPE与危险因素之间单变量关联的比值比。然后我们使用逻辑回归拟合一个调整模型,以评估BPE(高与低)与危险因素之间的关联,包括乳腺钼靶密度。

结果

大多数女性的BPE较低(84%)。在多变量模型中,我们发现BPE与年龄(P = 0.002)和体重指数(P = 0.03)之间存在统计学显著关联。我们确实发现全身孕激素用药与BPE之间存在显著关联,但由于数量较少,结果应谨慎解释。密度为D的女性(与B相比)高BPE的调整比值比为3.1,密度为C的女性(与B相比)为2.1。然而,高BPE与密度之间的关联在统计学上并不显著。我们未发现与任何其他危险因素存在统计学显著关联。

结论

我们的研究证实了BPE与年龄和体重指数之间已知的关联。尽管我们的结果显示随着乳腺钼靶密度水平的增加,高BPE的可能性更高,但这种关联在统计学上并不显著。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/7720360/b00dd37c1aef/10.1177_0284185120911583-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/7720360/b00dd37c1aef/10.1177_0284185120911583-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a0/7720360/b00dd37c1aef/10.1177_0284185120911583-fig1.jpg

相似文献

1
The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI.动态对比增强乳腺MRI中乳腺癌危险因素与乳腺实质背景强化之间的关联。
Acta Radiol. 2020 Dec;61(12):1600-1607. doi: 10.1177/0284185120911583. Epub 2020 Mar 26.
2
Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.乳腺癌与 MRI 背景实质增强的相关性:IMAGINE 病例对照研究。
Breast Cancer Res. 2020 Dec 7;22(1):138. doi: 10.1186/s13058-020-01375-7.
3
Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.背景实质强化对不同筛查性乳腺 MRI 高危患者人群癌症风险的影响。
AJR Am J Roentgenol. 2019 Mar 19;212(6):1412-1418. doi: 10.2214/AJR.18.20566.
4
Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.基于人群的 MRI 背景实质增强与未来原发性乳腺癌风险的相关性评估。
J Clin Oncol. 2019 Apr 20;37(12):954-963. doi: 10.1200/JCO.18.00378. Epub 2019 Jan 9.
5
Mammographic density, MRI background parenchymal enhancement and breast cancer risk.乳腺密度、MRI 背景实质增强与乳腺癌风险。
Ann Oncol. 2013 Nov;24 Suppl 8(Suppl 8):viii37-viii41. doi: 10.1093/annonc/mdt310.
6
Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.正常乳腺实质的乳腺MRI对比增强动力学与乳腺癌的存在相关。
Breast Cancer Res. 2016 Jul 22;18(1):76. doi: 10.1186/s13058-016-0734-0.
7
Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.乳腺 MRI 背景实质强化(BPE)的组织病理学特征。
Breast Cancer Res Treat. 2018 Nov;172(2):487-496. doi: 10.1007/s10549-018-4916-6. Epub 2018 Aug 23.
8
Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status.乳腺 MRI 下定量背景实质增强与纤维腺体密度:与 BRCA 状态的相关性。
Eur Radiol. 2023 Sep;33(9):6204-6212. doi: 10.1007/s00330-023-09592-2. Epub 2023 Apr 5.
9
MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women.MRI 脑实质增强、绝经后妇女的乳房密度和血清激素。
Int J Cancer. 2018 Aug 15;143(4):823-830. doi: 10.1002/ijc.31370. Epub 2018 Mar 25.
10
The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.背景实质强化在乳腺 MRI 与乳腺癌的相关性:一项系统评价和荟萃分析。
Radiology. 2019 Sep;292(3):552-561. doi: 10.1148/radiol.2019182441. Epub 2019 Jun 25.

引用本文的文献

1
Increased background parenchymal enhancement on peri-menopausal breast magnetic resonance imaging.围绝经期乳腺磁共振成像中背景实质强化增加。
Eur J Radiol Open. 2024 Nov 18;13:100611. doi: 10.1016/j.ejro.2024.100611. eCollection 2024 Dec.
2
Background parenchymal enhancement on contrast-enhanced mammography: associations with breast density and patient's characteristics.背景实质增强在对比增强乳腺摄影中的表现:与乳腺密度和患者特征的关系。
Radiol Med. 2024 Sep;129(9):1303-1312. doi: 10.1007/s11547-024-01860-5. Epub 2024 Jul 26.
3
Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.

本文引用的文献

1
Mammographic Density Change and Risk of Breast Cancer.乳腺密度变化与乳腺癌风险。
J Natl Cancer Inst. 2020 Apr 1;112(4):391-399. doi: 10.1093/jnci/djz149.
2
Does three-dimensional functional infrared imaging improve breast cancer detection based on digital mammography in women with dense breasts?基于数字乳腺摄影的三维功能红外成像是否能提高致密乳腺女性乳腺癌的检出率?
Eur Radiol. 2019 Nov;29(11):6227-6235. doi: 10.1007/s00330-019-06248-y. Epub 2019 May 21.
3
A Meta-analysis of the Diagnostic Performance of Diffusion MRI for Breast Lesion Characterization.
定量评估背景实质强化与筛查 MRI 中的乳腺癌终生风险相关。
Eur Radiol. 2024 Oct;34(10):6358-6368. doi: 10.1007/s00330-024-10758-9. Epub 2024 Apr 29.
4
Obesity and metabolic dysfunction correlate with background parenchymal enhancement in premenopausal women.肥胖和代谢功能障碍与绝经前妇女的背景实质增强相关。
Obesity (Silver Spring). 2023 Feb;31(2):479-486. doi: 10.1002/oby.23649. Epub 2023 Jan 11.
5
MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women.MRI背景实质强化、乳腺密度与乳腺癌风险因素:一项针对绝经前后女性的横断面研究。
NPJ Breast Cancer. 2022 Aug 25;8(1):97. doi: 10.1038/s41523-022-00458-2.
6
Analysis of risk factors associated with breast cancer in women: a systematic review and meta-analysis.女性乳腺癌相关危险因素分析:一项系统评价与Meta分析
Transl Cancer Res. 2022 May;11(5):1344-1353. doi: 10.21037/tcr-22-193.
磁共振弥散成像对乳腺病变特征诊断性能的 Meta 分析。
Radiology. 2019 Jun;291(3):632-641. doi: 10.1148/radiol.2019182510. Epub 2019 Apr 23.
4
Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.背景实质强化对不同筛查性乳腺 MRI 高危患者人群癌症风险的影响。
AJR Am J Roentgenol. 2019 Mar 19;212(6):1412-1418. doi: 10.2214/AJR.18.20566.
5
Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.乳腺磁共振筛查项目中纤维-腺体组织(FGT)和背景实质强化(BPE)与乳腺癌风险和假阳性的关系:一项回顾性队列研究。
Eur Radiol. 2019 Sep;29(9):4678-4690. doi: 10.1007/s00330-019-06020-2. Epub 2019 Feb 22.
6
Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.基于人群的 MRI 背景实质增强与未来原发性乳腺癌风险的相关性评估。
J Clin Oncol. 2019 Apr 20;37(12):954-963. doi: 10.1200/JCO.18.00378. Epub 2019 Jan 9.
7
Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.乳腺 MRI 背景实质强化(BPE)的组织病理学特征。
Breast Cancer Res Treat. 2018 Nov;172(2):487-496. doi: 10.1007/s10549-018-4916-6. Epub 2018 Aug 23.
8
Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk.高危筛查 MRI 背景实质强化与未来乳腺癌风险的关系。
Acad Radiol. 2019 Jan;26(1):69-75. doi: 10.1016/j.acra.2018.03.013. Epub 2018 Mar 27.
9
MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women.MRI 脑实质增强、绝经后妇女的乳房密度和血清激素。
Int J Cancer. 2018 Aug 15;143(4):823-830. doi: 10.1002/ijc.31370. Epub 2018 Mar 25.
10
Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.肥胖与乳腺癌不良风险及预后:机制洞察与干预策略
CA Cancer J Clin. 2017 Sep;67(5):378-397. doi: 10.3322/caac.21405. Epub 2017 Aug 1.